Pterostilbene-mediated microbiota shifts: Implications and opportunities.

Area of Science:

• Microbiome research
• Nutraceutical science
• Pharmacology

Background:

• Pterostilbene, a natural compound from blueberries and medicinal plants, is recognized for its potential health benefits.
• Its influence on gut microbiota composition is increasingly observed in various disease models.
• Existing research highlights pterostilbene's role in disease prevention and immune regulation, partly via microbial modulation.

Purpose of the Study:

• To synthesize current knowledge on pterostilbene's gut microbiota-modulating effects.
• To identify specific bacterial taxa consistently affected by pterostilbene supplementation.
• To analyze the physiological significance of these microbial alterations.

Main Methods:

• Narrative review of existing scientific literature.
• Focus on studies investigating pterostilbene's impact on gut microbial composition.
• Analysis of bacterial genera frequently influenced by pterostilbene.

Main Results:

• Pterostilbene supplementation demonstrably alters gut microbiota profiles across various models.
• Enrichment of beneficial genera, including Akkermansia, Bifidobacterium, Faecalibacterium prausnitzii, Roseburia, and Lactobacillus, is frequently observed.
• These microbial shifts are linked to enhanced intestinal barrier function, immune homeostasis, and short-chain fatty acid production.

Conclusions:

• Pterostilbene effectively modulates the gut microbiome, promoting the growth of health-associated bacteria.
• Microbiota alterations induced by pterostilbene contribute to its therapeutic potential, particularly as a microbiota-targeted agent.
• Findings support further research into pterostilbene within microbiome science and traditional medicine contexts.